title: New developments in the anti-neoplastic drug management of ovarian cancer.
abstract: Over the past several years, there have been a number of relevant evidence-based randomized trials that have the potential to change the standard management paradigm in the malignancy of ovarian cancer and (most importantly) enhance clinically relevant outcomes. This commentary will briefly review these trials.
authors.affiliation: Cancer Treatment Centers of America, Eastern Regional Medical Center 1331 East Wyoming Avenue, Philadelphia, PA 19124 USA.
authors.forename: Maurie
authors.initials: M
authors.lastname: Markman